1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TREML4 CTRPv2 pan-cancer AAC -0.082 0.01
mRNA MLANA CTRPv2 pan-cancer AAC -0.091 0.01
mRNA RP11-668G10.2 CTRPv2 pan-cancer AAC -0.082 0.01
mRNA NLE1 CTRPv2 pan-cancer AAC -0.086 0.01
mRNA POU1F1 CTRPv2 pan-cancer AAC 0.083 0.01
mRNA PRR11 CTRPv2 pan-cancer AAC -0.086 0.01
mRNA E2F3 CTRPv2 pan-cancer AAC 0.087 0.01
mRNA RBBP4 CTRPv2 pan-cancer AAC 0.096 0.01
mRNA FSD1L CTRPv2 pan-cancer AAC 0.083 0.01
mRNA NR2F1 CTRPv2 pan-cancer AAC 0.084 0.01
Download CSV